|
Therapy Area
Treatment of hepatitis C virus infection.
|
|
|
In phase
Preclinical development stage in collaboration with Tibotec, Johnson & Johnson.
|
|
Competitive Edge
Potent HCV polymerase inhibitors has been identified.
|
Project Data
Candidate Drug (CD) was selected in December 2008.
|
|
|
|
|
|